← back to search

Evelina Tacconelli

University Hospital Cologne · IT
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Pneumocystis jirovecii pneumonia detection and treatment, and Antibiotic Use and Resistance.
h-index
45
citations
6,671
works
204
NIH funding
primary concept
Medicine
email

Recent publications

An Antibiotic Stewardship Program in Pancreatic Surgery
JAMA Network Open 2025cited by 3position: middledoi
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Clinical Microbiology and Infection 2024cited by 113position: middledoi
<i>Candida glabrata</i> (<i>Nakaseomyces glabrata</i>): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List
Medical Mycology 2024cited by 31position: middledoi
European Society of Clinical Microbiology and Infectious Diseases/European Committee on infection control clinical guidelines on pre-operative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria before surgery
Clinical Microbiology and Infection 2024cited by 21position: middledoi
Antibiotic stewardship program in pancreatic surgery: a multicenter, before-after analysis.
Pancreatology 2024cited by 0position: middledoi
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Critical Care 2023cited by 47position: middledoi
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery
Clinical Microbiology and Infection 2022cited by 85position: lastdoi
SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers
Vaccines 2022cited by 30position: middledoi
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases
Clinical Microbiology and Infection 2022cited by 11position: middledoi
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic
Journal of Global Antimicrobial Resistance 2021cited by 56position: middledoi
Vitamin D and disease severity in coronavirus disease 19 (COVID-19)
Reumatismo 2021cited by 26position: middledoi
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
Cell Death and Differentiation 2021cited by 22position: middledoi
Monitoring approaches for health-care workers during the COVID-19 pandemic
The Lancet Infectious Diseases 2020cited by 330position: middledoi
Microbiota-associated Risk Factors for <i>Clostridioides difficile</i> Acquisition in Hospitalized Patients: A Prospective, Multicentric Study
Clinical Infectious Diseases 2020cited by 16position: middledoi
High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals
Journal of Antimicrobial Chemotherapy 2018cited by 9position: middledoi
Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control
Antimicrobial Resistance and Infection Control 2017cited by 294position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jesús Rodríguez‐Baño · Instituto de Salud Carlos III3 papers (2017–2022)Alex W. Friedrich · University Hospital Münster2 papers (2022–2024)Marion Koopmans · Erasmus MC2 papers (2020–2022)Herman Goossens · University of Antwerp2 papers (2021–2022)Christian Eckmann · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2022–2024)Eirini Christaki · Brown University2 papers (2022–2024)Gabriele Sganga · KU Leuven2 papers (2022–2024)Alessandro Visentin · University of Padua2 papers (2022–2024) · 2 papers (2022–2024) · 2 papers (2022–2024)Elda Righi · University of Padua2 papers (2022–2024) · 2 papers (2022–2024)Julia Bielicki · University of Lausanne2 papers (2020–2022)Nico T. Mutters · DKFZ-ZMBH Alliance2 papers (2022–2024) · 2 papers (2022–2024) · 2 papers (2022–2024)Stéphan Harbarth · World Health Organization1 papers (2022–2022) · 1 papers (2024–2024) · 1 papers (2017–2017)Sylvie van der Werf · Centre National de la Recherche Scientifique1 papers (2020–2020)